Cholecystokinin, dopamine D2 and N-methyl-D-aspartate binding sites in the nucleus of the solitary tract of the rat: Possible relationship to ingestive behavior

Neuroscience

Volumn 77, Issue 4, 1997, Pages 1077-1089

  Qian, M ^a   Johnson, A E ^b   Kallstrom L ^b   Carrer, H ^c   Sodersten P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c NONE

Author keywords

cholecystokinin; dopamine; glutamate; ingestive behavior; nucleus of the solitary tract

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 2,3,4,5 TETRAHYDRO 8 IODO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; DEVAZEPIDE; DIZOCILPINE; DOPAMINE 2 RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 5,6 DIMETHOXYSALICYLAMIDE; RADIOLIGAND; RECEPTOR SUBTYPE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; 8 SULFOCHOLECYSTOKININ OCTAPEPTIDE; 8-SULFOCHOLECYSTOKININ OCTAPEPTIDE; AMINO ACID RECEPTOR BLOCKING AGENT; DIAGNOSTIC AGENT; DIZOCILPINE MALEATE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; NOOTROPIC AGENT; RADIOACTIVE IODINE; SALICYLAMIDE DERIVATIVE; TRITIUM;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SOLITARY TRACT NUCLEUS; ANIMAL; ANIMAL BEHAVIOR; CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; FEEDING BEHAVIOR; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; DIZOCILPINE MALEATE; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; FEEDING BEHAVIOR; IODINE RADIOISOTOPES; MALE; NOOTROPIC AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHOLECYSTOKININ; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SALICYLAMIDES; SINCALIDE; SOLITARY NUCLEUS; TRITIUM;

EID: 0030611741     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00538-6     Document Type: Article

References (8)

1. 125I]cholecystokinin octapeptide binding in the ventromedial hypothalamic nucleus. Evidence for downmodulation by estrogen. Neuroendocrinology 45, 257-262.
2. 1 receptors in brain demonstrated with digital subtraction autoradiography. J. Neurosci. 7, 213-222.
3. Altschuler S. M., Escardo J., Lynn R. B. and Miselis R. R. (1993) The central organization of the vagus nerve innervating the colon of the rat. Gastroenterology 104, 502-509.
4. Bednar I., Forsberg G., Lindén A., Qureshi G. A. and Södersten P. (1991) Involvement of dopamine in inhibition of food intake by cholecystokinin octapeptide in male rats. J. Neuroendocr. 3, 491-496.
5. Bednar I., Qureshi G. A. and Södersten P. (1992) A comparison between the effect of cholecystokinin octapeptide and apomorphine on ingestion of intraorally administered sucrose in male rats. J. Neuroendocr. 4, 727-734.
6. Bednar I., Qureshi G. A. and Södersten P. (1992) Evidence that release of dopamine is involved in the inhibitory effect of cholecystokinin octapeptide on ingestion of intraorally administered sucrose in male rats. J. Neuroendocr. 4, 735-741.
7. Bednar I., Qian M., Qureshi G. A., KällstrÖm L., Johnson A. E., Carrer H. and Södersten P. (1994) Glutamate inhibits ingestive behaviour. J. Neuroendocr. 6, 403-408.
8. 2 antagonists enhance inhibition of consummatory ingestive behavior by CCK-8. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38), R896-R903.